Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LowEr Administered Dose With highEr Relaxivity: Gadovist vs Dotarem (LEADER 75)

NCT03602339 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03602339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03602339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LowEr Administered Dose With highEr Relaxivity: Gadovist vs Dotarem (LEADER 75)
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
November 14, 2018
Completion date
May 26, 2020
Enrollment
157 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

magnetic resonance imaging